-
1 Comment
Jiang Zhong Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 16.9% above its 200 day moving average.
From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.
Jiang Zhong Pharmaceutical Co.,Ltd's total revenue sank by 5.3% to $706M since the same quarter in the previous year.
Its net income has dropped by 7.6% to $76M since the same quarter in the previous year.
Finally, its free cash flow fell by 239.4% to $-39M since the same quarter in the previous year.
Based on the above factors, Jiang Zhong Pharmaceutical Co.,Ltd gets an overall score of 2/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000M80 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | 4.8% |
|---|---|
| PE Ratio | 19.2 |
| Target Price | 29.41 |
| Beta | 0.23 |
| Market Cap | 16B |
China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, Fritillaria and loquat capsules, bezoar and snake gallbladder Fritillaria liquid, and compound gold melon seed. It also provides health consumer and other products, such as nourishing, rehabilitation nutrition, gastrointestinal health, and liver health products. In addition, the company offers prescription drugs comprising traditional Chinese medicine products, which includes Shenbao capsules, Paishi granules, Huangba Shengmai drink, Bazhen Yimu capsules, Zhenju Jiangya tablets, Shuangju granules, Zhikang tablets, Shuxiong granules, etc.; chemical medicine products, such as lumbrokinase enteric-coated capsules, Rabelagat sodium enteric-coated tablets, chloroprocaine hydrochloride, etc.; and medicinal materials which includes stir-fried Chinese jujube seeds, French pinellia, and vinegar-soaked northern bupleurum. The company was formerly known as Jiang Zhong Pharmaceutical Co.,Ltd and changed its name to China Resources Jiangzhong Pharmaceutical Co.,Ltd in January 2025. China Resources Jiangzhong Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Nanchang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600750.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
